You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Policy & Regulation
Humacyte submits Israel MAA for Symvess arterial trauma repair
Login
Username:

Password:


Related Headlines

BioDlink named 'Emerging CDMO of the Year' at Asia-Pacific Biopharma Excellence Awards

Vimgreen Pharmaceuticals receives IND clearance for VG081821 in China

Emerald Clinical Trials honoured with 2026 Asia Pacific Biopharma Excellence Award

Inimmune reports dosing of first patient in Phase 2 allergen challenge chamber trial of INI-2004

WuXi Biologics wins at 2026 Asia-Pacific Biopharma Excellence Awards for leadership in bioprocessing, manufacturing excellence, and digital innovation

Precision for Medicine opens new Japan office

Gesynta Pharma doses first patient in vipoglanstat Phase 2 clinical proof-of-concept trial

Avene partners with BotDesign to advance clinical studies in dermo-cosmetics

AnaCardio secures US patent for AC01, extending protection until 2042

Dexcom highlights new diabetes outcomes and product roadmap at ATTD 2026

Curatis and Neupharma partner to develop corticorelin for peritumoral brain edema in Japan

Samsung Biologics collaborates with Lilly for new Gateway Labs site in Korea

Citius Oncology reports positive topline results from Phase 1 clinical trial of LYMPHIR combination

CMIC agrees agentic AI partnership with Bluenote

GenomOncology partners with WeTrials to support CNS cancer clinical trials

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026